Pharmafile Logo
Pharmafocus logo
Advanced Search

Biotium launches new DNA gel analysis technology

June 17, 2025
Business Services, Research and Development Biotium, Corporate, DNA gel analysis, DNAzure blue nucleic acid gel stain, glo-plate white photoactivation device, life sciences reagents

Biotium has announced the launch of its new glo-plate white photoactivation device, a compact LED-powered light box designed to support …

News
Bowel cancer screening image

Scientists discover reason for resistance to bowel cancer treatment

June 17, 2025
Research and Development Cancer Research UK, Oncology, The Institute of Cancer Research, bowel cancer, drug resistance

Scientists funded by Cancer Research UK have demonstrated what may cause some treatments to stop working in people living with …

News

Johnson & Johnson presents promising data on leukaemia treatment

June 16, 2025
Medical Communications, Research and Development European Hematology Association, Janssen-Cilag, Johnson & Johnson, Oncology, chronic lymphocytic leukaemia, clinical trial

Janssen-Cilag, a Johnson & Johnson company, has announced results from a matching-adjusted indirect comparison presented at this year’s European Hematology …

News

GCI Health appoints Aneeb Sharif as EMEA head of policy

June 16, 2025
Business Services, Medical Communications, Public Relations Corporate, EMEA Head of Policy, GCI Health, healthcare communications agency, healthcare policy analysis, patient advocacy, public affairs

Healthcare communications agency, GCI Health, has announced the appointment of Aneeb Sharif as Europe, Middle East and Africa (EMEA) head …

Appointment

Roche advances treatment for Parkinson’s disease

June 16, 2025
Research and Development Neurology, Parkinson's disease, Roche, clinical trials, neurodegenerative disease

Swiss biopharma, Roche, has announced its decision to proceed with phase 3 trials of prasinezumab, an investigational therapy for Parkinson’s …

News
handshake

Shilpa Medicare and Orion partner, expanding into European market

June 16, 2025
Manufacturing and Production Corporate, Orion Corporation, Shilpa Biocare, Shilpa Medicare, commercial supply agreement, plasma protein, recombinant human albumin

Shilpa Biocare, a wholly owned subsidiary of Shilpa Medicare, has signed a commercial supply agreement with Finland-based Orion Corporation for …

News
lab

Bristol Myers Squibb reports positive results for psoriatic arthritis treatment

June 13, 2025
Medical Communications, Research and Development European Alliance of Associations for Rheumatology, Rheumatology, bristol myers squibb, clinical trial, psoriatic arthritis

Bristol Myers Squibb (BMS) has presented new data from its phase 3 POETYK PsA-1 trial, showing that Sotyktu (deucravacitinib) significantly …

News

EpiEndo publishes new data supporting glasmacinal’s potential in COPD

June 13, 2025
Medical Communications, Research and Development Chronic Diseases, EpiEndo Pharmaceuticals, Fraunhofer Institute for Toxicology and Experimental Medicine, antimicrobial resistance, chronic obstructive pulmonary disease (COPD), lung disease

EpiEndo Pharmaceuticals has announced the publication of three peer-reviewed articles in Pulmonary Pharmacology and Therapeutics, highlighting the therapeutic potential of …

News

PM Society and CIM launch new leadership programme for pharma marketers

June 13, 2025
Sales and Marketing CIM Fellowship, Chartered Institute of Marketing (CIM), Corporate, Marketing Excellence Industry Group, PM Society Awards, Pharmaceutical Marketing (PM) Society, Pharmacy, partnership

The Pharmaceutical Marketing (PM) Society has partnered with the Chartered Institute of Marketing (CIM) to launch the PMS & CIM …

News

Digital platform for hypertension management launches in Europe

June 13, 2025
Business Services, Technical Consultancy Chronic Diseases, HealthTech, Newel Health, digital platform, high blood pressure, hypertension management, hypertension therapy

Newel Health, a European healthtech company specialising in digital medical devices, has announced that Amicomed, its digital platform for hypertension …

News

PL BioScience appoints Oliver Dick as chief technology officer

June 12, 2025
Clinical trials supplies & documentation logistics, Manufacturing and Production, Research and Development Corporate, Devices, Human Platelet Lysate, PL Bioscience, animal-free cell culture, life sciences

PL BioScience, a German life sciences company specialising in the production and development of human platelet lysate (HPL) for cell …

Appointment

Ascend granted certification for quality control testing at Munich facility

June 12, 2025
Contract Manufacturing, Manufacturing Services, Manufacturing and Production Adeno-associated (AAV)-based gene therapy., Ascend Advanced Therapeutics, Devices, Pharmacy, adeno-associated gene therapy, contract development and manufacturing organisation, good manufacturing practice certification, manufacturing site

Ascend Advanced Therapies, a contract development and manufacturing organisation based in Maryland, US, has received good manufacturing practice (GMP) certification …

News
handshake

Chiesi partners with Key2Brain to develop therapies for rare neurodegenerative diseases

June 12, 2025
Manufacturing and Production, Mergers and Acquisitions, Research and Development Chiesi Group, Key2Brain, Neurology, Rare Diseases, lysosomal storage disorders, neurodegenerative disease, partnership, ultra-rare disease

Italian biopharma, Chiesi Group, and Key2Brain, a Swedish biotech, have agreed to advance the development of two blood-brain barrier (BBB)-crossing …

News

Treatment for serious eye disease approved in Scotland

June 12, 2025
Market Access, Marketing Services, Research and Development, Sales and Marketing LYTENAVA, Opthalmology, Scottish Medicines Consortium, clinical programme, european union, eye disease, market approval, strategic partnership, united kingdom, wet age-related macular degeneration

Outlook Therapeutics has announced the Scottish Medicines Consortium (SMC) approval of Lytenava (bevacizumab gamma) for the treatment of wet age-related …

News
cellectis

PEPperPRINT launches new peptide microarray platform on 15th anniversary

June 11, 2025
Biotech/start-up, Research and Development, Sales and Marketing Devices, PEPperPRINT, biotech research, peptide microarray platform

German biotech PEPperPRINT has marked its 15th anniversary with the launch of a new peptide microarray platform, combinatorial laser-induced forward …

News

Meteor Biotech opens site at UCLA to support biotech research

June 11, 2025
Biotech/start-up, Research and Development, Sales and Marketing Devices, Immunology, Meteor Biotech, Oncology, Pharmacy, University of California Los Angeles, cell sorting technology, clinical trials, research facility

South Korean spatial omics specialist, Meteor Biotech, has announced the opening of its first international office at the California NanoSystems …

News
handshake_2

BioDuro and Silicogenix collaborate to advance non-traditional drug development

June 11, 2025
Manufacturing Services, Manufacturing and Production, Research and Development BioDuro, Oncology, Pharmacy, Silicogenix, contract research, contract research development and manufacturing organisation (CRDMO), drug development

BioDuro, a contract research, development and manufacturing organisation, has announced a strategic partnership with small molecule design specialist Silicogenix (SGX) …

News
clinical_trials

Dupixent improves symptoms in patients with skin of colour, study shows

June 11, 2025
Advocacy Development, Medical Education, Research and Development Dermatology, Dupixent, Regeneron, Sanofi, atopic dermatitis, dermatology, underserved populations

Sanofi and Regeneron have announced results from the collaborative phase 4 DISCOVER study, presented at the Revolutionizing Atopic Dermatitis Conference, …

News

Lubrizol announces an important milestone for its novelpatented excipient, Apisolex™ polymer

June 10, 2025
Research and Development Apisolex polymer, Good Manufacturing Practices (GMP) guidelines, Lubrizol, Pharmacy, clinical trial

June 10, 2025 – Lubrizol announces that an Apisolex™ polymer excipient-enabled drugformulation is in Phase 1 clinical trials. Introduced to …

News
Press release

Takeda presents positive results from trial of chronic kidney disease treatment

June 10, 2025
Research and Development European Renal Association, Immunology, Nephrology, Takeda, autoimmune disease, immunoglobulin A nephropathy (IgAN), kidney disease

Takeda Pharmaceuticals has announced positive results from a proof-of-concept study of mezagitamab (TAK-079) to treat patients with primary immunoglobulin A …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026